We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRVN
13151
CALL
DELISTED
Trevena, Inc.
TRVN
$7.72K ﹤0.01%
512
-1,640
-76% -$35.5K
FAZE
13152
CALL
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$7.71K ﹤0.01%
46,500
-200
-0.4% -$62
GROY icon
13153
PUT
Gold Royalty Corp
GROY
$727M
$7.68K ﹤0.01%
6,000
-12,000
-67% -$19K
BLRX
13154
PUT
BioLineRX
BLRX
$12M
$7.64K ﹤0.01%
105
+102
+3,400% +$6.85K
DAO
13155
CALL
Youdao
DAO
$2.17B
$7.64K ﹤0.01%
1,900
TIXT
13156
CALL
DELISTED
TELUS International
TIXT
$7.62K ﹤0.01%
1,000
-2,500
-71% -$23.8K
AMRX icon
13157
PUT
Amneal Pharmaceuticals
AMRX
$6.32B
$7.6K ﹤0.01%
1,800
-3,000
-63% -$11.2K
BAB icon
13158
CALL
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
$7.59K ﹤0.01%
300
-16,800
-98% -$436K
SWI
13159
PUT
DELISTED
SolarWinds Corporation Common Stock
SWI
$7.55K ﹤0.01%
800
-600
-43% -$6.3K
EPSN icon
13160
Epsilon Energy
EPSN
$169M
$7.5K ﹤0.01%
+1,421
New +$7.92K
LTRN icon
13161
CALL
Lantern Pharma
LTRN
$33.9M
$7.5K ﹤0.01%
2,200
+2,000
+1,000% +$9.08K
IYF icon
13162
PUT
iShares US Financials ETF
IYF
$4.43B
$7.48K ﹤0.01%
100
-300
-75% -$23.1K
CSBR icon
13163
CALL
Champions Oncology
CSBR
$70.4M
$7.46K ﹤0.01%
1,200
-6,000
-83% -$37.9K
TUSK icon
13164
PUT
Mammoth Energy Services
TUSK
$160M
$7.42K ﹤0.01%
1,600
-3,700
-70% -$18K
ICVT icon
13165
PUT
iShares Convertible Bond ETF
ICVT
$7.67B
$7.42K ﹤0.01%
100
-400
-80% -$30.4K
NEXN
13166
CALL
Nexxen International
NEXN
$583M
$7.41K ﹤0.01%
+2,100
New +$11.6K
FNUC
13167
PUT
Frontier Nuclear and Minerals Inc
FNUC
$47.9M
$7.41K ﹤0.01%
438
+407
+1,313% +$10.1K
CLSD
13168
CALL
DELISTED
Clearside Biomedical
CLSD
$7.39K ﹤0.01%
567
SJB icon
13169
CALL
ProShares Short High Yield
SJB
$47.6M
$7.38K ﹤0.01%
400
-2,000
-83% -$36.7K
DOGZ icon
13170
CALL
Dogness International Corp
DOGZ
$16.8M
$7.38K ﹤0.01%
785
-40
-5% -$532
NUVB.WS
13171
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$7.33K ﹤0.01%
73,313
-45
-0.1% -$6
TCOA.WS
13172
DELISTED
Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
TCOA.WS
$7.33K ﹤0.01%
+39,329
New +$7.26K
MPRAW
13173
DELISTED
Mercato Partners Acquisition Corporation Warrant
MPRAW
$7.32K ﹤0.01%
34,869
-404,639
-92% -$43.8K
LPRO
13174
PUT
DELISTED
Open Lending Corp
LPRO
$7.32K ﹤0.01%
1,000
-8,300
-89% -$75.9K
ALKT icon
13175
PUT
Alkami Technology
ALKT
$2.21B
$7.29K ﹤0.01%
400
-10,400
-96% -$175K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.